Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors.

Fazzino TL, Klemp J, Befort C.

Breast Cancer Res Treat. 2018 Apr;168(3):755-761. doi: 10.1007/s10549-017-4603-z. Epub 2017 Dec 22.


Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.

Bandos H, Melnikow J, Rivera DR, Swain SM, Sturtz K, Fehrenbacher L, Wade JL 3rd, Brufsky AM, Julian TB, Margolese RG, McCarron EC, Ganz PA.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx162.


Chronic and episodic stress predict physical symptom bother following breast cancer diagnosis.

Harris LN, Bauer MR, Wiley JF, Hammen C, Krull JL, Crespi CM, Weihs KL, Stanton AL.

J Behav Med. 2017 Dec;40(6):875-885. doi: 10.1007/s10865-017-9855-x. Epub 2017 May 20.


Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Mikelman S, Mardirossian N, Gnegy ME.

J Chem Neuroanat. 2017 Oct;83-84:50-58. doi: 10.1016/j.jchemneu.2016.08.004. Epub 2016 Aug 30. Review.


Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.

Kadakia KC, Snyder CF, Kidwell KM, Seewald NJ, Flockhart DA, Skaar TC, Desta Z, Rae JM, Otte JL, Carpenter JS, Storniolo AM, Hayes DF, Stearns V, Henry NL.

Oncologist. 2016 May;21(5):539-46. doi: 10.1634/theoncologist.2015-0349. Epub 2016 Mar 23.


The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.

Nugent BD, Sereika SM, Rosenzweig M, McCue M, Merriman JD, Bender CM.

Support Care Cancer. 2016 Aug;24(8):3401-9. doi: 10.1007/s00520-016-3161-y. Epub 2016 Mar 17.


Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study.

Ganz PA, Petersen L, Bower JE, Crespi CM.

J Clin Oncol. 2016 Mar 10;34(8):816-24. doi: 10.1200/JCO.2015.64.3866. Epub 2016 Jan 19.


Dispositional and Situational Avoidance and Approach as Predictors of Physical Symptom Bother Following Breast Cancer Diagnosis.

Bauer MR, Harris LN, Wiley JF, Crespi CM, Krull JL, Weihs KL, Stanton AL.

Ann Behav Med. 2016 Jun;50(3):370-84. doi: 10.1007/s12160-015-9763-7.


Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Ganz PA, Cecchini RS, Julian TB, Margolese RG, Costantino JP, Vallow LA, Albain KS, Whitworth PW, Cianfrocca ME, Brufsky AM, Gross HM, Soori GS, Hopkins JO, Fehrenbacher L, Sturtz K, Wozniak TF, Seay TE, Mamounas EP, Wolmark N.

Lancet. 2016 Feb 27;387(10021):857-65. doi: 10.1016/S0140-6736(15)01169-1. Epub 2015 Dec 11.


Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.

Land SR, Walcott FL, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

J Natl Cancer Inst. 2015 Nov 27;108(4). pii: djv365. doi: 10.1093/jnci/djv365. Print 2016 Apr.


Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.

Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A.

J Sex Med. 2014 Dec;11(12):3102-11. doi: 10.1111/jsm.12684. Epub 2014 Aug 21.


A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.

Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.


Protocol and recruitment results from a randomized controlled trial comparing group phone-based versus newsletter interventions for weight loss maintenance among rural breast cancer survivors.

Befort CA, Klemp JR, Fabian C, Perri MG, Sullivan DK, Schmitz KH, Diaz FJ, Shireman T.

Contemp Clin Trials. 2014 Mar;37(2):261-71. doi: 10.1016/j.cct.2014.01.010. Epub 2014 Jan 31.


Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.

Bartula I, Sherman KA.

Breast Cancer Res Treat. 2013 Sep;141(2):173-85. doi: 10.1007/s10549-013-2685-9. Epub 2013 Sep 8. Review.


Pretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.

Wickersham KE, Sereika SM, Bender CM.

Nurs Res. 2013 Jul-Aug;62(4):243-51. doi: 10.1097/NNR.0b013e318298fd70.


The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.

Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ.

Clin Breast Cancer. 2013 Oct;13(5):325-34. doi: 10.1016/j.clbc.2013.02.014. Epub 2013 Jun 28.


The effect of a community-based exercise intervention on symptoms and quality of life.

Knobf MT, Thompson AS, Fennie K, Erdos D.

Cancer Nurs. 2014 Mar-Apr;37(2):E43-50. doi: 10.1097/NCC.0b013e318288d40e.


Outcomes of a weight loss intervention among rural breast cancer survivors.

Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, Fabian CJ.

Breast Cancer Res Treat. 2012 Apr;132(2):631-9. doi: 10.1007/s10549-011-1922-3. Epub 2011 Dec 25.


Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400. doi: 10.1158/1940-6207.CAPR-11-0172. Epub 2011 Aug 23.


Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors.

Befort CA, Klemp J.

J Womens Health (Larchmt). 2011 Sep;20(9):1307-13. doi: 10.1089/jwh.2010.2308. Epub 2011 Jun 28.

Supplemental Content

Support Center